Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 275 of 715 entries
View as:

12-week Efficacy of Indacaterol

Phase: N/A Priority: Normal
NCT ID: NCT01072448 Org: User:
Start: 01/31/10 End: 07/31/10 Due: 07/31/11

Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Phase: N/A Priority: Normal
NCT ID: NCT00426218 Org: User:
Start: 12/31/06 End: - Due: -

Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)

Phase: N/A Priority: Normal
NCT ID: NCT02382913 Org: User:
Start: 04/30/15 End: 06/30/15 Due: 06/30/16

Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids

Phase: N/A Priority: Normal
NCT ID: NCT00658320 Org: User:
Start: 02/29/08 End: 05/31/12 Due: 05/31/13

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

Phase: N/A Priority: Normal
NCT ID: NCT00143026 Org: User:
Start: 07/31/05 End: 06/30/06 Due: 06/30/07

A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT00260923 Org: User:
Start: 11/30/05 End: 11/30/06 Due: 11/30/07

Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA)

Phase: N/A Priority: Normal
NCT ID: NCT01967550 Org: User:
Start: 10/31/13 End: 05/31/14 Due: 05/31/15

Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00219258 Org: User:
Start: 07/31/05 End: - Due: -

Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam

Phase: N/A Priority: Normal
NCT ID: NCT00427505 Org: User:
Start: 07/31/06 End: - Due: -

Efficacy of DNK333 in Patients With COPD and Cough

Phase: N/A Priority: Normal
NCT ID: NCT01287325 Org: User:
Start: 09/30/03 End: - Due: -

EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Phase: N/A Priority: Normal
NCT ID: NCT00470678 Org: User:
Start: 06/30/07 End: 11/30/08 Due: 11/30/09

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01001572 Org: User:
Start: 09/30/09 End: 05/31/10 Due: 05/31/11

Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT01167153 Org: User:
Start: 05/31/10 End: 04/30/11 Due: 04/30/12

Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00841672 Org: User:
Start: 01/31/09 End: 09/30/09 Due: 09/30/10

Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01237223 Org: User:
Start: 10/31/10 End: 05/31/11 Due: 05/31/12

Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.

Phase: N/A Priority: Normal
NCT ID: NCT00500539 Org: User:
Start: 07/31/07 End: 09/30/08 Due: 09/30/09

Single Dose Study to Assess the Safety, Tolerability, Concentration in Body and Effect of BAF312

Phase: N/A Priority: Normal
NCT ID: NCT00422175 Org: User:
Start: 10/31/06 End: 11/30/07 Due: 11/30/08

An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT00228059 Org: User:
Start: 01/31/05 End: 07/31/07 Due: 07/31/08

Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction

Phase: N/A Priority: Normal
NCT ID: NCT00460577 Org: User:
Start: 03/31/07 End: 09/30/08 Due: 09/30/09

Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00170950 Org: User:
Start: 10/31/03 End: 05/31/08 Due: 05/31/09

Effect of Food on the Pharmacokinetics of AQW051 in Japanese Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00409500 Org: User:
Start: 10/31/06 End: - Due: -

Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT02141516 Org: User:
Start: 05/31/14 End: 03/31/15 Due: 03/31/16

Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00705575 Org: User:
Start: 06/30/08 End: 04/30/09 Due: 04/30/10

Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine

Phase: N/A Priority: Normal
NCT ID: NCT00416962 Org: User:
Start: 08/31/06 End: 12/31/06 Due: 12/31/07

Effects of AFQ056 and Nicotine in Reducing Cigarette Smoking

Phase: N/A Priority: Normal
NCT ID: NCT00414752 Org: User:
Start: 09/30/06 End: - Due: -